- Date
- 11/02/2009
- Text to display
- N/A
- Subject
- Extension on AHRQ Draft TA Review
- Content
- Review extended for Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment
Review Extension: Due to a delay in the distribution of the review announcement to the TA Program e-mail list, the review period for the technology assessment draft on targeted therapies for cancer will be extended until November 16, 2009. This draft is entitled "Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment." If you are interested in reviewing this document, please visit: http://www.ahrq.gov/clinic/ta/tareview.htm. The document will be available for review until 5:00 PM on November 16, 2009. If you have any questions, please contact ahrqtap@ahrq.hhs.gov.
